One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between Afrigen Biologics and the Univercells Group intends to pave the way for the development of the first-ever African-owned COVID-19 vaccine. The collaboration will focus on the development of a novel mRNA vaccine using intellectual property from the collaboration partners, as well as developing new IP, and is intended to supercharge access to the vaccine. Afrigen and Univercells will be supported i...